Reply  by Kanemitsu, Shinji et al.
LETTERS TO THE EDITOR
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1Regarding “Molecular diagnosis of nonaneurysmal
infectious aortitis”
We read with great interest the case report by Kanemitsu et al1
showing the identification of bacterial species in infected, although
not dilated, aortitis, which had been successfully treated surgically.
Although themortality rate of infected aortic aneurysm seems to have
dropped in recent years,2 infected aortic aneurysm is still a diagnostic
and therapeutic challenge. Considering nonelective surgery or non-
operation increases the risk of aneurysm-related death,2 and early
diagnosis of infected aortitis, followed by timely surgical intervention
is, without doubt, beneficial to the patient.
In this case, however, Kanemitsu et al1 reported increased
serum levels of immunoglobulin (Ig) G4 and high infiltration of
IgG4-positive plasma cells in the adventitia of the descending
aorta, both of which are characteristics of inflammatory aortic
aneurysm and idiopathic retroperitoneal fibrosis. These disor-
ders share similar clinical and histopathologic features and are
both thought to result from an exaggerated inflammatory re-
sponse to advanced atherosclerosis. In contrast to infected
aortic aneurysm, inflammatory aortic aneurysm is presumed to
be less susceptible to rupture, and corticosteroid therapy may be
effective in controlling the perianeurysmal inflammation.3 In
the absence of definitive diagnostic criteria for inflammatory
aortic aneurysm, however, the selection of immunosuppressive
therapy is sometimes a challenging option, and thus overindi-
cation should be avoided.
Results of blood culture can be negative in up to 50% of
patients with an infected aortic aneurysm,4 and the prevalence of
elevated serum IgG4 levels in patients with infected aortic aneu-
rysm is not known. Despite these limitations, retroperitoneal fibro-
sis, rather than the infected aortitis, seems to be a more suitable
diagnosis of the presented case, according to the serologic and
immunohistochemical findings. Again, surgical intervention of the
infected aorta, before it manifests apparent aneurysmal formation,
may be an excellent choice for the management for this patient,
especially considering that the aorta may show prominent enlarge-
ment over a short period of time and that arterial rupture can occur
without aneurysm formation.5 Nevertheless, this case presentation
raises fundamental questions:
1. Did this patient have both IgG4-related chronic periaortitis and
aortic wall infection?
2. Do the authors think that Ig4-related periaortic inflammation
has a role in the development of bacterial infection-induced
aortic wall remodeling, leading to aneurysmal formation, which
is suggested in the pathogenesis of inflammatory aortic
aneurysm?
Nobukazu Ishizaka, MD
Division of Cardiology
Osaka Medical College
Osaka, Japan
Aiko Sakamoto, MD
Department of Cardiovascular Medicine
University of Tokyo Graduate School of Medicine
Tokyo, Japan
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We thank Drs Ishizaka and Sakamoto for their interest in our
rticle1 and are happy to reply to their comments. There is a close
elationship between immunoglobulin (Ig) G4-related inflamma-
ion and fibrous sclerosing lesions. IgG4-related sclerosing disease
s clinically characterized by high serum IgG4 concentrations and is
ssociated with multiple lesions in different organs. It can occur in
he cardiovascular system and can manifest as an inflammatory
bdominal aortic aneurysm (AAA).2 Sclerosing inflammation in
he aortic wall sometimes extends into fibroadipose connective
issue around the aorta, and these cases are known as inflammatory
AAs associated with retroperitoneal fibrosis.3
It is controversial whether a correlation exists between bacte-
ial infected aortic disease and IgG4-related inflammatory aortitis.
n our reported patient, histochemical analysis showed IgG4-
elated aortitis and, simultaneously, the molecular diagnostic tech-
iques of broad-range polymerase chain reaction and DNA se-
uencing revealed bacterial aortic wall infection.
We have no conclusive evidence that IgG4-related aortic
nflammation has a positive role in the development of bacterial
nfection–induced aortic wall remodeling, leading to aneurysmal
ormation. We speculate that the aortic wall infection was second-
ry to the IgG4-related inflammatory abdominal aortitis. Medial
egeneration in the aorta is often due to medial laminar necrosis
esulting from inflammatory processes.2 We speculate that bacte-
ial infection extends to the aortic intimal wall and then infiltrates
nto the media, which results in a degenerative change due to
gG4-related inflammatory aortitis. The clinicopathologic charac-
eristics of IgG4-related sclerosing disease in the aorta remain
nclear.
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Endoleaks and the unending saga of a clever new
terminology that has proved counterproductive
Incomplete aneurysm exclusion, both early and late, was iden-
tified as a unique complication of endovascular repair since its
inception.1,2 The phenomenon was increasingly recognized in the
mid-1990s as several authors noted the presence of “leaks” to
signify persistence (or recurrence) of paragraft flow.3–5 White et al
were first to describe the growing problem with clarity and coined
a brand-new term6: “We propose a preferable, novel terminology –
endoleak – for this new phenomenon, which is associated only with
endoluminal grafts.” The clever new term was received enthusias-
tically and adopted rapidly the world over.
For vascular surgeons, endoleak describes accurately the phe-
nomenon of incomplete aneurysm exclusion. Unfortunately, ev-
eryone else in the medical community remains focused on the leak
portion of the term, as it elicits deep-rooted mental images of a
ruptured or rupturing aorta. While nuanced enough for vascular
specialists, the differentiation intended by adding the prefix
endo-to compose a wholly new word and concept failed to achieve
its goal because it retained “leak” within the new term. The result:
countless instances of unnecessary scare and anguish as physicians
and patients become concerned – even panicked – by the thought
of possible aortic rupture.
Nearly 15 years have passed and the endoleak saga contin-
ues to grow larger and increasingly problematic. Mainly, three
factors combine to explain the current state of affairs: the rise of
stent graft intervention as the new standard of care for most
abdominal aortic aneurysm (AAA) patients; the prevalence of
endoleaks after endovascular repair; and the enormous prolifer-
ation of computed tomography (CT) scan studies in the popu-
lation at large.
Is there anything we can do now, can we extract the “leak” out
of endoleaks? Is it too late to restore “sanity” with a new terminol-
ogy that would serve us equally well to denote incomplete aneu-
rysm exclusion but without any suggestion of a “leaking aneu-
rysm?” Several such terms have been used in published reports over
the years, such as paragraft flow, persistent flow, incomplete exclu-
sion, and the like. Among them, sac flow impresses me as the best
candidate term to replace endoleak, as it is simple and precise,
unique to aneurysms, and does not carry any hidden or overt
implication of a potentially life-threatening situation. A contrast-
enhanced CT scan (or ultrasound study) could be reported as
showing evidence of sac flow or no evidence of sac flow.Moreover,
sac flow could be further characterized as type I, type II, etc., in the
exact same manner as endoleaks are classified today.
That said, I fully recognize mine is just a small voice in the
wilderness. To resonate, a proposal of this kind will need to elicit
enough interest from endovascular experts around the world who
can, in turn, propel the discussion to higher levels. Furthermore,
and ultimately, the major vascular and endovascular societies – and
other stakeholders, regulators included – would have to become
involved and embrace the cause. In the end, I feel strongly that
resolution of this problem would result in significant benefit to our
patients, and to us all.
Frank J. Criado, MD, FACSUnion Memorial Hospital/MedStar Health
Baltimore, Md
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Thank you for the opportunity to reply to this letter. If Dr
riado is correct, and the sky is indeed falling,1 then it is highly
nlikely that the solution lies in the simple substitution of a new
eologism (“sac flow”)2 for an older and well-tried neologism
“endoleak”).3
On the other hand, if the folk of Baltimore are truly facing an
ngoing “unending saga,” including “unnecessary scare and an-
uish,” resulting in both “physicians and patients panicked,”2 then
t may be best to initially look for a local solution, since such a state
f panic does not appear to be widespread! I fail to perceive how
he term “sac flow” could simply solve this problem, since by Dr
riado’s own logic, many outside the vascular community would
ow be forced to reinterpret new “deep-rooted mental images” of
owing blood and sacs. In addition, the term “endoleak” also
efines the fact that an endovascular graft is present, whereas “sac
ow” does not.
We proposed the term endoleak in 1996 precisely for the
urpose of differentiating this new condition from the phenome-
on of ruptured or leaking abdominal aortic aneurysm (AAA),3
nd as an aid in providing a specific defined term and a classification
ystem to help determine the long-term outcomes for the various
ypes of endoleak that were being recognized in the early years of
ndovascular grafting.4,5 For example, this classification has helped
normously in showing that type II endoleaks do not require
ntervention in the high majority of cases.5 It is difficult to take at
ace value Dr Criado’s claim that “no other parts of the medical
ommunity have been able to comprehend the differentiation in
he intervening 15 years, and that the simple use of a diagnostic
erm has elicited an “unending saga.”
A useful starting point for guiding the radiologists of
altimore (or other regions of anguish) would be a series of
ecommendations for reporting post-endograft studies, which
ould always include a statement of the maximum size and
ntegrity of an AAA or other aneurysm, as well as the presence or
bsence of endoleak and how it influences flow in the sac (“sac
ow”). This system seems to work well for the rest of the world!
t is difficult to see how a report that states that “type II
ndoleak is present, and is causing retrograde blood flow into
he sac from a lumbar artery, without any evidence of AAA
xpansion or signs of AAA rupture” could be an inducer of
anic. Such reporting guidelines are readily available from the
6merican College of Radiology, and elsewhere. Also of con-
ern in this letter is the implication that most US patients are
